Jeremy Warner, MD, MS, FAMIA, FASCO

@hemoncwarner.bsky.social

923 Followers 1222 Following

Professor of Medicine and Biostatistics at Brown University, Director of the Center for Clinical Cancer Informatics and Data Science (CCIDS), CTO of HemOnc.org, co-founder of the COVID-19 and Cancer Consortium (CCC19), EIC of JCO CCI. Views my own.

Graphical abstract accompanying the published article.
Use of a remote monitoring app was similar across sociodemographic characteristics, and more frequent app use was associated with a higher likelihood of 6-month adjuvant endocrine therapy adherence for hormone receptor positive breast cancer. Encouraging women to monitor medication adherence and communicate adverse symptoms could improve adjuvant endocrine therapy adherence.
Last updated on 2024-12-02: 38 regimens on this page; 55 variants on this page